Antibody Response to CoronaVac Vaccine in Indonesian COVID-19 Survivor
View ORCID ProfileRahmat Azhari Kemal, Dita Kartika Sari, Ariza Julia Paulina
doi: https://doi.org/10.1101/2021.05.28.21254613
Rahmat Azhari Kemal
1Department of Medical Biology, Faculty of Medicine, Universitas Riau, Pekanbaru, Indonesia; and Biomolecular Laboratory, Arifin Achmad General Hospital of Riau Province, Pekanbaru, Indonesia
Dita Kartika Sari
2Department of Anatomy, Faculty of Medicine, Universitas Riau, Pekanbaru, Indonesia
Ariza Julia Paulina
3Department of Clinical Pathology, Faculty of Medicine, Universitas Riau, Pekanbaru, Indonesia
Data Availability
-
Posted May 29, 2021.
Antibody Response to CoronaVac Vaccine in Indonesian COVID-19 Survivor
Rahmat Azhari Kemal, Dita Kartika Sari, Ariza Julia Paulina
medRxiv 2021.05.28.21254613; doi: https://doi.org/10.1101/2021.05.28.21254613
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (715)
- Anesthesia (210)
- Cardiovascular Medicine (2990)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12875)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4671)
- Geriatric Medicine (428)
- Health Economics (736)
- Health Informatics (2971)
- Health Policy (1079)
- Hematology (395)
- HIV/AIDS (942)
- Medical Education (434)
- Medical Ethics (116)
- Nephrology (479)
- Neurology (4452)
- Nursing (239)
- Nutrition (654)
- Oncology (2317)
- Ophthalmology (659)
- Orthopedics (261)
- Otolaryngology (330)
- Pain Medicine (288)
- Palliative Medicine (85)
- Pathology (505)
- Pediatrics (1208)
- Primary Care Research (506)
- Public and Global Health (7052)
- Radiology and Imaging (1565)
- Respiratory Medicine (927)
- Rheumatology (447)
- Sports Medicine (389)
- Surgery (495)
- Toxicology (60)
- Transplantation (214)
- Urology (186)